Park Place Capital’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $72.2K | Sell |
1,520
-9,852
| -87% | -$468K | 0.02% | 295 |
|
|
2025
Q1 | $694K | Sell |
11,372
-1,391
| -11% | -$84.8K | 0.19% | 93 |
|
|
2024
Q4 | $722K | Sell |
12,763
-599
| -4% | -$33.9K | 0.2% | 101 |
|
|
2024
Q3 | $691K | Buy |
13,362
+4,509
| +51% | +$233K | 0.2% | 105 |
|
|
2024
Q2 | $368K | Buy |
8,853
+114
| +1% | +$4.73K | 0.12% | 157 |
|
|
2024
Q1 | $474K | Buy |
8,739
+5,083
| +139% | +$276K | 0.17% | 139 |
|
|
2023
Q4 | $188K | Sell |
3,656
-1,767
| -33% | -$90.7K | 0.07% | 230 |
|
|
2023
Q3 | $315K | Sell |
5,423
-1,900
| -26% | -$110K | 0.09% | 181 |
|
|
2023
Q2 | $468K | Buy |
7,323
+1,587
| +28% | +$101K | 0.13% | 151 |
|
|
2023
Q1 | $398K | Buy |
5,736
+526
| +10% | +$36.5K | 0.11% | 170 |
|
|
2022
Q4 | $375K | Buy |
+5,210
| New | +$375K | 0.11% | 173 |
|